Hims & Hers Health recently acquired Trybe Labs.
The purchase will lead to more accessible and affordable home blood draws and testing. The details of the agreement have not been shared, but Hims & Hers told msn that “the deal was completed through cash on hand and is expected to roll out over the next year.” Testing costs will be disclosed then.
Test offerings will include: “LDL cholesterol, lipoprotein(a), cholesterol and apolipoprotein.” Additionally, treatment for low testosterone, menopause, and perimenopause will be included.
Patients “will be given a blood lancet provided by home diagnostic testing company Tasso.” The lancet is designed to draw patients’ blood with the push of a button. Data will be sent to clinicians for analysis. Furthermore, Hims & Hers hopes to “use data from the blood work — with patient identities removed — to accelerate its development of artificial intelligence-powered healthcare.”
